Continued Smoking Exacerbates but Cessation Ameliorates Progression of Early Type 2 Diabetic Nephropathy  Kantima Phisitkul, MD, Khaled Hegazy, MD, Temduang.

Slides:



Advertisements
Similar presentations
Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages (January.
Advertisements

Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Sickle Cell Trait With Chronic Kidney.
Date of download: 9/16/2016 From: Should All Patients with Type 1 Diabetes Mellitus and Microalbuminuria Receive Angiotensin-Converting Enzyme Inhibitors?:
Urinary cotinine measurement in patients with Buerger's disease—Effects of active and passive smoking on the disease process  Masahiro Matsushita, MD,
Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente  Mark Rutkowski, MD, Wendy Mann, PharmD, Stephen Derose,
Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus  S. Nakatani, E.
Vatsal Ladia, MD, Hemang B. Panchal, MD, MPH, Terrence J
Todd W. Rice, MD, Gordon R. Bernard, MD 
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis  Stavros Stavrakis, MD  The American Journal.
Transient Left Bundle Branch Block: An Unusual Electrocardiogram in Acute Pulmonary Embolism  Rahil Kasmani, MD, MRCP, Kelechi Okoli, MD, MRCP, Geetali.
Type 4 Hiatal Hernia The American Journal of the Medical Sciences
Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD 
Efficacy of Rifaximin, a Nonabsorbed Oral Antibiotic, in the Treatment of Small Intestinal Bacterial Overgrowth  Marek Majewski, MD  The American Journal.
Efficacy of Two Different Helicobacter pylori Eradication Regimens in Patients With Type 2 Diabetes and the Effect of Helicobacter pylori Eradication.
Role of Microalbuminuria in Predicting Cardiovascular Mortality in Individuals With Subclinical Hypothyroidism  Tushar A. Tuliani, MD, Maithili Shenoy,
Hypertension-Lipid Connection: Introduction
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Chronic Kidney Disease in Diabetes
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure  Mikhail Kosiborod, Ingrid Gause-Nilsson, John Xu,
Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart FailureClinical Perspective by Satoshi.
Proteinuria predicts postcardiotomy acute kidney injury in patients with preserved glomerular filtration rate  Szu-Yuan Li, MD, Chiao-Lin Chuang, MD,
Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional.
Volume 76, Pages S3-S11 (December 2009)
Diagnosis and Management of Chronic Kidney Disease
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
The predictive value of s-cystatin C for mortality after coronary artery bypass surgery  Alain Dardashti, MD, PhD, Shahab Nozohoor, MD, PhD, Lars Algotsson,
Volume 79, Issue 12, Pages (June 2011)
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration.
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets  David M. Spiegel, Kate Brady  Kidney.
Chronic Kidney Disease in Diabetes
Peter Rossing, Philip Hougaard, Hans-Henrik Parving 
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome
‘Progressive diabetic nephropathy. How useful is microalbuminuria
Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.
Volume 81, Issue 7, Pages (April 2012)
Your Kidneys May Outlive You
The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study  Mohamed G. Atta, MD, MPH, Kesha Baptiste-Roberts,
Erratum American Journal of Kidney Diseases
Volume 69, Pages S11-S15 (April 2006)
Volume 63, Issue 4, Pages (April 2003)
The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population  Claudine T. Jurkovitz, MD, MPH, Yang Qiu,
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Renal risk scores: Progress and prospects
Quiz Page July 2012 American Journal of Kidney Diseases
Statins and other agents for vascular inflammation
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Volume 76, Issue 3, Pages (August 2009)
Within-Person Variability in Kidney Measures
Drug Dose Adjustments in Patients With Renal Impairment
Methods for guideline development
Lesley A. Stevens, MD, MS, Nicholas Stoycheff, MD 
Volume 85, Issue 5, Pages (May 2014)
Preoperative Smoking Cessation: The Role of the Primary Care Provider
Study protocol. Study protocol. Fourteen patients had research renal biopsies, and 17 patients with macroalbuminuria had renal biopsies for clinical reasons.
Mean mesangial area (micron2) across normal controls (normal C), patients with type 2 diabetes and normoalbuminuria (normo), patients with type 2 diabetes.
Journal of Investigative Dermatology
Journal of Investigative Dermatology
Volume 58, Issue 2, Pages (August 2000)
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Two-year changes in albumin-to-creatinine ratio across microalbuminuria at baseline. Two-year changes in albumin-to-creatinine ratio across microalbuminuria.
Friends, social networks, and progressive chronic kidney disease
Lipoprotein abnormalities in diabetic nephropathy
National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary  Peter A. McCullough, MD, MPH, Joseph A.
Volume 73, Issue 11, Pages (June 2008)
GDF-15 levels in progressors and nonprogressors in albuminuria (case and control subjects) for patients with T2DM and nondiabetic patients with HT. A:
Volume 86, Issue 2, Pages (August 2014)
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Continued Smoking Exacerbates but Cessation Ameliorates Progression of Early Type 2 Diabetic Nephropathy  Kantima Phisitkul, MD, Khaled Hegazy, MD, Temduang Chuahirun, MD, Cathy Hudson, CCRC  The American Journal of the Medical Sciences  Volume 335, Issue 4, Pages 284-291 (April 2008) DOI: 10.1097/MAJ.0b013e318156b799 Copyright © 2008 Southern Society for Clinical Investigation Terms and Conditions

Figure 1 Glomerular filtration rate estimated using the modification of diet in renal disease formula (eGFR) during 5-year follow-up of the first cohort of prospectively followed, nonsmoking subjects with type 2 diabetes mellitus (DM2) and either normoalbuminuria (Normo), microalbuminuria (Micro), or macroalbuminuria (Macro). *P < 0.05 versus Normo; +P < 0.05 versus Micro. The American Journal of the Medical Sciences 2008 335, 284-291DOI: (10.1097/MAJ.0b013e318156b799) Copyright © 2008 Southern Society for Clinical Investigation Terms and Conditions

Figure 2 Urine albumin excretion (UalbuminV) expressed as albumin (mg)-to-creatinine (g) ratio in a spot morning specimen of the first cohort of prospectively followed, nonsmoking Normo, Micro, or Macro DM2 subjects during the 5-year follow-up. *P < 0.05 versus respective baseline value. The American Journal of the Medical Sciences 2008 335, 284-291DOI: (10.1097/MAJ.0b013e318156b799) Copyright © 2008 Southern Society for Clinical Investigation Terms and Conditions

Figure 3 Urine cotinine excretion (UcotinineV) during 5-year follow-up in the second cohort of prospectively followed DM2 subjects with early nephropathy (microalbuminuria) who were nonsmokers, continued smokers, and quitting smokers. *P < 0.05 versus nonsmokers. The American Journal of the Medical Sciences 2008 335, 284-291DOI: (10.1097/MAJ.0b013e318156b799) Copyright © 2008 Southern Society for Clinical Investigation Terms and Conditions

Figure 4 Urine albumin excretion (UalbuminV) expressed as albumin (mg)-to-creatinine (g) ratio in a spot morning specimen during the 5-year follow-up in the second cohort of prospectively followed DM2 subjects with early nephropathy (microalbuminuria) who were nonsmokers, continued smokers, and quitting smokers. *P < 0.05 versus nonsmokers. The American Journal of the Medical Sciences 2008 335, 284-291DOI: (10.1097/MAJ.0b013e318156b799) Copyright © 2008 Southern Society for Clinical Investigation Terms and Conditions

Figure 5 Urine excretion of isoprostane 8-prostaglandin F2α (U8-isoV), expressed as (μg)-to-creatinine (g) ratio in a spot morning specimen during 5-year follow-up in the second cohort of prospectively followed DM2 subjects with early nephropathy (microalbuminuria) who were nonsmokers, continued smokers, and quitting smokers. *P < 0.05 versus nonsmokers. The American Journal of the Medical Sciences 2008 335, 284-291DOI: (10.1097/MAJ.0b013e318156b799) Copyright © 2008 Southern Society for Clinical Investigation Terms and Conditions